Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Studies show FOXO4-DRI treatment reduces senescent cell burden by 50-70% in various tissues including liver, kidney, and adipose tissue within weeks of treatment initiation in aged mice
GHK-Cu is studied for collagen synthesis, glycosaminoglycans, extracellular matrix remodeling, fibroblast activity, inflammation, and wound repair mechanisms 4, 5
Payment options and financing are available
Injectable is systemic and reported as faster in user diaries
Studies examining ischemic wounds reveal GHK-Cu treatment decreases concentrations of metalloproteinases 2 and 9 along with tumor necrosis factor-beta compared to vehicle-treated or untreated wounds
Yara iyilemesini , doku yeniden ekillenmesini , iltihap nleyici aktiviteyi ve cilt yenilenmesini destekleme potansiyeli asndan kapsaml bir ekilde incelenmitir
US$ 29.58
US$ 27.77
US$ 27.08
